About this record
The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Max-Planck-Institut für Plasmaphysik |
|---|---|
| Country | Germany |
| Category | Pharmaceuticals |
| CPV | 85310000 |
| Published | January 20, 2023 |
| Procurement stage | Active solicitation |
| Closed | Closing date not published |
| Status | Closed — no longer accepting responses |
| Last verified | October 11, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in Germany
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Interferon beta-1b (ATC: L03AB08)
See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free Germany Pharmaceuticals intelligence report in your inbox
A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.